Azithromycin in bronchiolitis obliterans syndrome

Phase 4

Completed

• Conditions: Respiratory; Bronchiolitis obliterans syndrome; Other chronic obstructive pulmonary disease

• Registration Number: ISRCTN36220396
• Lead Sponsor: Katholieke Universiteit Leuven and University Hospitals Leuven (Belgium) - Lab of Pneumology, Lung Transplant Unit

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2009-12-17
• Last Update Posted: 17 October 2016

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

1. Stable LTx recipients at discharge after transplantation
2. Signed informed consent
3. Adult of either sex (aged at least 18 years old at moment of transplantation)
4. Able to take oral medication

Exclusion Criteria

1. Prolonged and/or complicated intensive care unit (ICU) course after lung transplantation
2. Early (less than 30 days post-transplant) post-operative death
3. Major suture problems (airway stenosis or stent)
4. Retransplantation (lung)
5. Previous transplantation (solid organ)
6. Multi-organ transplantation (lung and other solid organ)

Study & Design

• Study Type: Interventional
• Study Design: Not specified